
Innovative Sterilization Technologies (IST) appointed Tim Tzimas as its new President and Chief Executive Officer, effective January 1, 2026.
Tzimas brings more than 25 years of leadership experience in the orthopedic, neurosurgical, and medical technology sectors, with a career focused on sales management, operations, and organizational development in regulated healthcare markets.
Most recently, Tzimas served as joint reconstruction sales manager for the New York Metro Branch at Stryker, where he led one of the company’s largest U.S. territories. There, he managed strategic sales, robotic system utilization, and oversaw a team of more than 25 sales, clinical, and operational professionals.
Tzimas steps into leadership at a time when cases are rapidly transitioning from inpatient to outpatient facilities, causing pressure to do more with less—higher case volumes, tighter margins, and growing regulatory demands. IST’s leadership believes Tzimas’s experience and perspective in the power of consolidating trays, enhancing workflows, and maximizing efficiencies, position the company to meet those challenges head-on while continuing to expand adoption of its flagship ONE TRAY system.
“Sterilization has long been treated as a necessary behind the scenes function, and in many ways the industry is still operating on outdated assumptions,” Tzimas said. “I want to help IST dispel existing dogma and change the perception in the market about how to best manage surgical instrument sterilization and containment.”
Under Tzimas’ leadership, IST plans to sharpen its focus on helping inpatient and outpatient facilities scale efficiently while maintaining the highest standards of safety and compliance. Wider adoption of ONE TRAY and EZ-TRAX will elevate surgical workflow at facilities challenged by limited space, excessive cost, disconnect in instrument delivery and processing of instrumentation.
“My goal is to help surgical facilities sustain increased volumes and long-term success,” Tzimas said. “When teams are less burdened by unnecessary steps and inefficiencies, they can focus on what matters most—patient care and operational excellence.”
Source: Innovative Sterilization Technologies
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



